[Federal Register Volume 88, Number 188 (Friday, September 29, 2023)]
[Notices]
[Pages 67328-67329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board (NCAB) and NCI Board of Scientific Advisors (BSA).
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
    A portion of the National Cancer Advisory Board meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(6), title 5 U.S.C., as amended. The intramural programs 
and projects and the discussions could disclose confidential trade 
secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the 
intramural programs and projects, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Date: November 29, 2023.
    Open: 5:30 p.m. to 9:00 p.m.
    Agenda: National Cancer Advisory Board Subcommittee Meetings.
    Place: Gaithersburg Marriott Washingtonian Center, Room--TBD, 
9751 Washington Boulevard, Gaithersburg, MD 20878.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340, <a href="/cdn-cgi/l/email-protection#0f687d6e767f4f626e66632161666721686079"><span class="__cf_email__" data-cfemail="fd9a8f9c848dbd909c9491d3939495d39a928b">[email protected]</span></a>.

    Name of Committee: National Cancer Advisory Board and NCI Board 
of Scientific Advisors.
    Date: November 30, 2023.
    Open: 8:00 a.m. to 4:15 p.m.
    Agenda: Joint meeting of the National Cancer Advisory Board and 
NCI Board of Scientific Advisors, NCI Director's Report and 
Presentations.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 & 408, Rockville, MD 20850.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340, <a href="/cdn-cgi/l/email-protection#81e6f3e0f8f1c1ece0e8edafefe8e9afe6eef7"><span class="__cf_email__" data-cfemail="a6c1d4c7dfd6e6cbc7cfca88c8cfce88c1c9d0">[email protected]</span></a>.

    Name of Committee: National Cancer Advisory Board.
    Date: November 30, 2023.
    Closed: 4:30 p.m. to 5:30 p.m.
    Agenda: Review of intramural program site visit outcomes and the 
discussion of confidential personnel issues.
    Place: National Cancer Institute--Shady Grove, 9609 Medical 
Center Drive, Room TE406 & 408, Rockville, MD 20850.
    Contact Person: Paulette S. Gray, Ph.D., Director, Division of 
Extramural Activities, National Cancer Institute--Shady Grove, 
National Institutes of Health, 9609 Medical Center Drive, 7th Floor, 
Room 7W444, Bethesda, MD 20892, 240-276-6340 <a href="/cdn-cgi/l/email-protection#c2a5b0a3bbb282afa3abaeecacabaaeca5adb4"><span class="__cf_email__" data-cfemail="d5b2a7b4aca595b8b4bcb9fbbbbcbdfbb2baa3">[email protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

[[Page 67329]]

    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NCI-Shady Grove campus. All 
visitors will be asked to show one form of identification (for 
example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: NCAB: http://deainfo.nci.nih.gov/advisory/ncab/ncab.htm, BSA: 
http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 26, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-21441 Filed 9-28-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>